CES1 Carriers in the PAPI Study

Clinical trial NCT03188705 · COMPLETED

Trial details

NCT number: NCT03188705
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Diseases Coronary Disease Coronary Artery Disease Cardiovascular Diseases Myocardial Ischemia Artery Occlusion Aspirin Sensitivity Clopidogrel, Poor Metabolism of Platelet Dysfunction Platelet Thrombus

Start date: 2019-10-14
Primary completion: 2020-01-17
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.